| Previous close | 66.16 |
| Open | 61.93 |
| Bid | 73.70 |
| Ask | 78.50 |
| Strike | 240.00 |
| Expiry date | 2024-06-21 |
| Day's range | 61.93 - 66.67 |
| Contract range | N/A |
| Volume | |
| Open interest | 21 |
GuruFocus.comInsider Sale: Director Christopher Causey Sells Shares of United Therapeutics Corp (UTHR)
United Therapeutics Corp, a biotechnology firm, focuses on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. Over the past year, Christopher Causey has engaged in multiple transactions, selling a total of 12,640 shares and purchasing none. Shares of United Therapeutics Corp were priced at $304.18 on the day of the sale.
GuruFocus.comInsider Sale: Director Judy Olian Sells Shares of United Therapeutics Corp (UTHR)
Director Judy Olian sold 1,700 shares of United Therapeutics Corp (NASDAQ:UTHR) on June 17, 2024, as reported in a recent SEC Filing.
ZacksAre You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
© 2024 Yahoo. All rights reserved.